| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.64B | $1.53B | $1.27B |
| YoY Revenue Growth % | +6.7% | +21.1% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.16B | $1.78B | $1.90B |
| Operating Margin % | 132.1% | 116.2% | 149.9% |
| Net Income (GAAP) | $1.83B | $1.51B | $1.61B |
| EBITDA (Normalized) | $2.22B | $1.84B | $1.94B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.21B | $2.00B | $2.96B |
| Capital Expenditures (CapEx) | $73.6M | $69.0M | $57.0M |
| Free Cash Flow (FCF) | $2.14B | $1.93B | $2.90B |
| FCF Margin % | 130.7% | 126.0% | 229.4% |
| Return on Invested Capital (ROIC %) | 1.9% | 1.6% | 16.4% |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $90.02B | $86.97B | $3.55B |
| Total Stockholders' Equity | $26.32B | $24.25B | $7.28B |